Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Monte Rosa Therapeutics Inc shares valued at $58,383 were purchased by Leo Chandra P. on Mar 24 ’25. At $5.84 per share, Leo Chandra P. acquired 10,000 shares. The insider’s holdings grew to 10,000 shares worth approximately $52600.0 following the completion of this transaction.
Also, Versant Venture Capital VI, L. sold 89,990 shares, netting a total of over 869,240 in proceeds. Following the sale of shares at $9.66 each, the insider now holds 2,007,948 shares.
Before that, Versant Venture Capital VI, L. had sold 67,905 shares from its account. In a trade valued at $621,801, the 10% Owner traded Monte Rosa Therapeutics Inc shares for $9.16 each. Upon closing the transaction, the insider’s holdings decreased to 67,905 shares, worth approximately $8.28 million.
As published in a research note from Wells Fargo on December 19, 2024, Monte Rosa Therapeutics Inc [GLUE] has been rated down from an Overweight to an Equal weight and the price target has been revised to $11 from $14. Analysts at Wedbush started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid February. As of January 03, 2023, Wells Fargo has increased its “an Equal weight” rating to a “an Overweight” for GLUE. Earlier on October 13, 2022, UBS initiated its rating. Their recommendation was “a Buy” for GLUE stock.
Analyzing GLUE Stock Performance
During the last five days, there has been a drop of approximately -25.50%. Over the course of the year, Monte Rosa Therapeutics Inc shares have dropped approximately -24.21%. Shares of the company reached a 52-week high of $7.46 on 01/03/25 and a 52-week low of $5.13 on 03/27/25. A 50-day SMA is recorded $6.15, while a 200-day SMA reached $6.07.
Support And Resistance Levels for Monte Rosa Therapeutics Inc (GLUE)
According to the 24-hour chart, there is a support level at 5.08, which, if violated, would cause prices to drop to 4.89. In the upper region, resistance lies at 5.50. The next price resistance is at 5.73. RSI (Relative Strength Index) is 37.26 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.70, which suggests the price will decrease in the coming days. Percent R is at 94.04%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
